Pembrolizumab in Combination With Gemcitabine in People With Advanced Mycosis Fungoides or Sézary Syndrome
The purpose of this study is to find out whether the combination of pembrolizumab and gemcitabine is an effective treatment for mycosis fungoides and Sézary syndrome.
Mycosis Fungoides|Mycosis Fungoides/Sezary Syndrome|Sezary Syndrome|Sézary|Advanced Mycosis Fungoides
DRUG: Gemcitabine|DRUG: Pembrolizumab
Overall Response Rate, Estimate overall response rate (ORR) using the composite global response criteria, 6 months
The purpose of this study is to find out whether the combination of pembrolizumab and gemcitabine is an effective treatment for mycosis fungoides and Sézary syndrome.